Literature DB >> 6520060

Epidemiology of clindamycin resistance in the Bacteroides fragilis group.

M Reig, M G Campello, F Baquero.   

Abstract

A study was made of trends in the susceptibility rates to clindamycin of 338 clinical strains of the Bacteroides fragilis group isolated in the period 1980-83. In 1980, the resistance rate of the species Bact. fragilis to 4 mg/l was only 3.3%, but this percentage increased regularly in 1981 (6.2%), 1982 (15.5%) and reached 19.6% in 1983. Resistance rates in other species of the group (Bact. distasonis, Bact. vulgatus, Bact. thetaiotaomicron) were already high in 1980 and no relevant increase has been documented since then. In order to asses the relationship between clindamycin resistance and hospitalization or macrolides-lincosamides consumption, 184 faecal strains of the Bact. fragilis group isolated from non-treated in-patients, out-patients and healthy volunteers were studied for clindamycin resistance. An unexpectedly high rate of resistance (around 25%) was found in all groups. Resistant strains appeared heterogeneous with regard to phagetype. For unknown reasons, clindamycin resistance seems to be widespread among intestinal Bacteroides strains of the human population, at least in our region.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6520060     DOI: 10.1093/jac/14.6.595

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

1.  Antibiotic sensitivity of the Bacteroides fragilis group in Europe. European Study Group.

Authors:  I Phillips; A King; C E Nord; B Hoffstedt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

2.  Selection of constitutively resistant mutants of inducible clindamycin-resistant Bacteroides vulgatus.

Authors:  M Reig; F Baquero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-08       Impact factor: 3.267

3.  Prevalence of macrolides-lincosamides-streptogramin B resistance and erm gene classes among clinical strains of staphylococci and streptococci.

Authors:  W D Jenssen; S Thakker-Varia; D T Dubin; M P Weinstein
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

4.  Transferable plasmid-linked chloramphenicol acetyltransferase conferring high-level resistance in Bacteroides uniformis.

Authors:  J V Martínez-Suárez; F Baquero; M Reig; J C Pérez-Díaz
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

Review 5.  Evolution in antibiotic susceptibility of Bacteroides fragilis group strains in France based on periodic surveys.

Authors:  L Dubreuil; M Derriennic; A Sedallian; C Romond; A L Courtieu
Journal:  Infection       Date:  1989 May-Jun       Impact factor: 3.553

6.  Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents.

Authors:  C Betriu; E Campos; C Cabronero; C Rodriguez-Avial; J J Picazo
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

7.  Changes in the susceptibility of Bacteroides fragilis group organisms to various antimicrobial agents 1979-1989.

Authors:  C Betriu; C Cabronero; M Gomez; J J Picazo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.